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Patient hopes for diagnostic genomic sequencing: roles
of uncertainty and social status
Cynthia M Khan*,1, Elizabeth G Moore2, Cristina Leos2 and Christine Rini2,3
For patients with unexplained or undiagnosed conditions, genomic sequencing offers the hope of resolving unanswered
questions. With the growth of clinical genomic sequencing, understanding factors that shape patients’ hope for information could
have important implications for developing patient education guidelines. Based on the goal-directed theory of hope, we
investigated illness uncertainty as a form of motivation and subjective social status as a form of perceived resources to predict
the amount and kinds of information that adult patients (N=191) and parents of pediatric patients (N=79) hoped to receive
from diagnostic sequencing results. Participants were part of a larger longitudinal study on clinical genomic sequencing, but the
current study focuses on their hopes for diagnostic sequencing results. Hopes for information were assessed through close-ended
and open-ended responses. Findings from mixed methods analyses indicated that although patients and parents hoped to learn
multiple kinds of information from diagnostic sequencing results, their hopes appeared to be influenced by their illness
uncertainty and perceptions of their social and economic resources. These findings suggest that patients’ illness uncertainty and
perceived resources could be useful avenues for discussing patient hopes and educating patients about strengths and limitations
of genomic sequencing.
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INTRODUCTION
For patients with serious illnesses, hope provides a sense of meaning
and stability and enables a positive outlook.1,2 For unexplained or
undiagnosed illnesses, diagnostic genomic sequencing increases the
likelihood of detecting a genetic explanation or diagnosis that could
help identify treatments and disease risk for family members.3 Yet,
uncertainty about the health implications of results will likely persist
due to current limitations in scientific and clinical knowledge and
sequencing technology.3 Prior studies reveal that at-risk adults,
patients, and parents of pediatric patients hope to learn different
kinds of information from diagnostic genomic sequencing results
(eg, genetic cause, treatment).4–6 One key question that has not been
addressed is why patients hope for different kinds of information.
Understanding factors that shape patient hope could inform the
development of patient education and counseling approaches that
foster hope in ways that acknowledge the strengths and limitations of
genomic sequencing.
One way to understand factors that shape patient hopes is to apply a
theoretical framework that takes into account the personal, inter-
personal, and environmental resources that are posited to influence
hope.7 The goal-directed theory of hope proposes that hope is shaped
by people’s motivation to pursue a desired outcome (ie, a goal) and
their perceived means to do so.8,9 Those with more motivation and
perceived means are posited to have more hope than those with less
motivation or perceived means. Given the salience of uncertainty and
resource demands (eg, the money, time, and social resources for
pursuing medical resolution) in patients with unexplained or undiag-
nosed conditions, the present study investigated illness uncertainty as a
form of motivation and subjective social status as a form of perceived
means to predict patients’ hopes for information from diagnostic
sequencing results.
Illness uncertainty – the inability to explain the cause of an illness,
define an illness, or make predictions about future health10,11 – can
undermine health-related decision making and psychological
adjustment.12,13 Such barriers posed by illness uncertainty may
increase patient motivation to learn more information from sequen-
cing results. In addition, people’s perceptions of their social and
economic resources could shape their views of genomic sequencing
and its health implications. People’s views of their social status in
terms of education, finances, and occupational prestige (ie, subjective
social status14) may influence how they see themselves, others, and
their situations.15 Subjective social status has been linked to mental
and physical health above and beyond objective indicators of socio-
economic status such as education and income.16 By extrapolation,
patients who see themselves as better resourced may feel more hopeful
about diagnostic genomic sequencing because they see more possibi-
lities to apply results to health decisions and medical resolution of
health concerns than patients who see themselves as less resourced.
Current study
We investigated the effects of illness uncertainty and subjective social
status on the number of kinds of information (eg, genetic explanation,
diagnosis, treatment) that adult patients and parents of pediatric
patients hoped to learn from their (or their child’s) diagnostic whole-
exome sequencing (WES). Patients and parents were part of an
ongoing longitudinal study that is investigating the feasibility of
applying genomic sequencing to clinical care. The current study
focuses on participant hopes for information from diagnostic
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sequencing results. To obtain a nuanced understanding of the nature
of participants’ hopes, content analysis was performed on their open-
ended responses about their main hope for information from WES.
Based on the goal-directed theory of hope,9 we hypothesized that more
illness uncertainty and a higher subjective social status would be
associated with participants hoping for more kinds of information.
MATERIALS AND METHODS
Participants
Adult patients (N= 191) and the parents of pediatric patients (N= 79) were
participating in the North Carolina Clinical Genomic Evaluation of Next-
generation Exome Sequencing study (NCGENES). Patients are referred to
NCGENES by physicians associated with the University of North Carolina
(Chapel Hill, NC, USA) and Vidant Medical System (Greenville, NC, USA).
Patients are eligible for NCGENES when they have a condition that is suspected
to have a genetic cause but has not been definitively explained or diagnosed. Of
the eligible patients (or parents of pediatric patients) contacted for study
participation as of June 2014 (N= 724), 347 enrolled (46.9%). Common
reasons for non-enrollment include inability to reach for scheduling (N= 119),
participant cancellation of clinic visits or no-shows (N= 72), or participant
refusal to participate owing to lack of interest or time or poor health (N= 55).
Procedures
All participants completed telephone surveys and mail-in questionnaires
approximately 2 weeks after study enrollment (Time 1) and approximately
2 weeks after receiving diagnostic WES results (Time 2). Adult patients
completed additional telephone surveys approximately 3 and 6 months after
receiving results. Telephone surveys are audio recorded, and all data are entered
in an electronic data storage system (Research Electronic Data Capture,
REDCap). Participants provided written consent before participation.
All procedures were approved by the Institutional Review Boards of the
University of North Carolina, Chapel Hill and Vidant Medical System. The
current study is based on Time 1 telephone surveys completed between
September 2012 and June 2014.
Measures
Illness uncertainty was assessed during the telephone survey using the 23-item
Illness Uncertainty Scale,17 which assesses agreement with statements about
cause, ability to define or characterize the illness, and future health implications
on a 5-point scale, 1 (strongly disagree) to 5 (strongly agree). Scale scores
followed a normal distribution (skewness=− 0.07; kurtosis=− 0.92), and the
scale demonstrated acceptable reliability (α= 0.91). Subjective social status was
assessed in a mail-in questionnaire using the Subjective SES Scale,14 which is an
image of a ladder with 10 rungs, with the lowest rung indicating people in the
United States with the worst resources (money, education, jobs) and the highest
rung indicating people with the best resources. Participants are instructed to
mark one rung on the ladder that corresponds with their sense of social status.
Subjective social status score followed a normal distribution (skewness=− 0.24;
kurtosis=− 0.24).
Hopes for information from WES results
Participant hopes for information from their (or their child’s) diagnostic WES
results were assessed in the telephone survey through: (1) a close-ended item
and (2) an open-ended item about the main thing they hoped to get from
results.
The close-ended item was, ‘I’d like to start by reading a list of things people
sometimes hope to get out of their [child’s] whole exome sequencing and
genetic counseling. As I read the list, I’d like you to tell me whether you are
hoping to get each of these things out of your [child’s] whole exome sequencing
and the genetic counseling you’ll get with it.’ Participants endorsed (yes/no) to
the following: ‘An explanation for your [child’s] health concern?’; ‘Reassurance,
or information to reduce your concerns?’; ‘Advice on how to manage your
[child’s] health concern?’; and ‘Help making treatment decisions?’. Participants
could also name something else they were hoping to get. One-quarter of
participants (n= 68) named an additional unique item, including information
about disease risk for family members and future health, helping others, and
helping advance genomic medicine. The endorsed items (including unique
items named by participants) were summed to create a score for the number of
kinds of information participants hoped to get. Scores followed a fairly normal
distribution (skewness=− 1.34; kurtosis= 2.21). The open-ended item was, ‘In
your own words, what is the main thing you hope to get out of your [child’s]
whole exome sequencing and genetic counseling?’
Analyses
The number of kinds of information participants hoped to learn. Hierarchical
linear regression was performed to investigate illness uncertainty and subjective
social status as predictors of the number of kinds of information that
participants hoped to learn. To control for potential influences of participants’
background and experiences, prior genetic testing, respondent role (adult
patient vs parent), race/ethnicity (non-Hispanic white vs other ethnicity/race
combinations), and patient functional status (standardized scores for adults18,19
and pediatric patients20) were entered as covariates in the first block. Because of
the potential overlap between objective socioeconomic status and race/ethnicity,
educational attainment (less than college degree vs college degree or higher) and
total household income (continuous) were entered separately in the second
block. Illness uncertainty and subjective social status were entered in the third
block to assess their effects above and beyond control variables, including
education and income. Power calculations for a sample size that takes into
account missing data on covariates (N~240), a small-to-moderate effect size,
and statistical significance at P= 0.0521 indicated sufficient statistical power
(40.95).
The main thing participants hoped to learn. Content analysis was conducted on
participants’ open-ended responses. The first two authors (CMK and EGM)
separately noted response patterns of the first 105 participants and came to an
agreement about major themes to include in a codebook as distinct codes
(eg, cause, future implications; Table 3). Participants who mentioned several
items in their responses were assigned multiple codes. Next, the second (EGM)
and third (CL) authors applied the codebook to separately conduct content
analysis for the first 125 participant responses. Across two separate coding
sessions, the inter-rater agreements (kappas) for coded responses ranged from
0.73 to 0.80 for the first coding session and from 0.69 to 0.72 for the second
session before discussion of coding disagreements. Disagreements were settled
by CMK. Given high inter-rater agreement, responses of remaining participants
(N= 144) were coded by EGM or CL. Questions about coding were resolved
among CMK, EGM, and CL. For participants who completed the subjective
social status item (N= 260), coded responses were stratified by low status
(scores 1–3), moderate status (scores 4–7), and high status (scores 8–10). Status
cutoffs were chosen to obtain a clearer differentiation of high status and low
status and used as a three-category status variable to investigate emergent
themes in responses.
RESULTS
The number of kinds of information participants hoped to learn
Demographic and study variable information are presented in Table 1.
On average, participants endorsed hoping to learn 3.87 (SD= 1.02)
kinds of information. Findings for illness uncertainty and subjective
social status were in line with predictions (Table 2). As participants’
illness uncertainty increased, they hoped for more kinds of informa-
tion from WES (β= 0.29, Po0.001). A marginal effect emerged for
subjective social status such that as participants’ subjective social status
increased they hoped for marginally more kinds of information
(β= 0.14, P= 0.077). Illness uncertainty and subjective social status
accounted for an additional 7.0% of the variance above and beyond
control variables, including education and income (Adj. R2= 0.12;
F change Po0.001).
The main thing participants hoped to get
Content analysis of participants’ open-ended responses (N= 269)
generated 10 distinct codes for information. As shown in Table 3,
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participants most commonly mentioned the following kinds of
information as a ‘main hope’: Cause of the illness (‘cause’; 44.2%);
directions for illness management (‘treatment’; 36.4%); identity or
name for the illness (‘diagnosis’; 26.8%); and disease risk for family
members (‘family implications’; 23.0%). Other items such as implica-
tions for future health (‘future implications’), illness prevention
(‘prevention’), or implications for having children (‘family planning’)
were mentioned by relatively few participants (≤12%). Smaller
percentages of participants hoped that their results would benefit
others (‘help others’) and advance research (‘advance science’). Over
half (54.1%) of the participants mentioned more than one kind of
information in their response.
Emergent themes in the kinds of information that participants
mentioned as a main hope and the language used to describe main
hopes were observed across social statuses. The majority (57.1%) of
low-status participants (N= 28) mentioned hoping to get information
about the cause of the illness. Moderate-status participants (N= 180)
were fairly broad in their main hopes, with over one-third hoping to
get information about the genetic cause (39.4%) or treatment for the
illness (39.4%) and over one-quarter (29.4%) hoping to get a
diagnosis. Nearly half of the high-status participants (N= 51) hoped
to get information about the cause of the illness (49.0%) or
information about disease risk in family members (41.2%).
A small subset of participants mentioned hoping to learn both the
cause of the illness and receive a diagnosis: 5 (17.9%) low-status
participants, 11 (6.1%) moderate-status participants, and 1 high-status
participant. Although content analysis of this small subset of partici-
pant responses precludes strong conclusions, we observed a tendency
of moderate-status participants to qualify their hopes with words such
as ‘maybe’ or ‘possible’ relative to low-status participants. For example,
one low-status adult patient said, ‘I hope to get an answer to what has
been affecting my vision and what exactly I have’. A moderate-status
parent tempered her hope by saying, ‘To know what happened that
caused him to have this disorder that he has. If possible, to know what
exactly his diagnosis is’.
Follow-up hierarchical logistic regression analyses were conducted
to investigate the effects of illness uncertainty and subjective social
status (status category variable) on whether or not participants
mentioned the four most common types of information as a main
hope: cause, treatment, diagnosis, and family implications. These
analyses controlled for participant role, prior genetic testing,
race/ethnicity, patient functional status, educational attainment, and
household income.
Cause
Participants’ illness uncertainty was not significantly associated with
the odds of mainly hoping to learn the cause (P= 0.927). However,
low-status participants were more likely to mention cause than
moderate-status participants (OR= 3.34; 95% CI= 1.30, 8.60;
P= 0.012).
Treatment
As participants’ illness uncertainty increased, their odds of mainly
hoping to learn about treatment increased by 4.90 (95% CI= 2.63,
9.12; Po0.001). There were no significant differences in the odds of
mentioning treatment across status categories (Ps40.200).
Diagnosis
As participants’ illness uncertainty increased, their odds of mainly
hoping to receive a diagnosis increased by 6.51 (95% CI= 3.12, 13.59;
Po0.001). Low-status participants were marginally more likely to
mention diagnosis than high-status participants (OR= 4.49; 95%
CI= 0.98, 20.56; P= 0.053). Moderate-status participants were
marginally more likely to mention diagnosis than high-status partici-
pants (OR= 3.13; 95% CI= 0.98, 10.04; P= 0.055).
Table 1 Participant sociodemographic and measures information
(N=270)
Variable Frequencies (%) Mean (SD)
Respondent role
Adult patients 70.7
Parents of pediatric patients 29.3
Respondent gender
Female 76.7
Respondent race/ethnicity
Non-Hispanic White 75.5
Hispanic/Latino 11.1
Black/African American 11.9
American Indian/Alaska Native 3.3
Asian 1.1
Other race 3.7
Respondent highest education level
High school or less 20.4
Some college (no degree) 20.7
Vocational program or associates degree 15.9
Bachelor's degree 25.6
Graduate or professional degree 17.4
Total household income (N=247)
o$45000 36.4
$45 000–$89 999 32.4
≥$90 000 31.2
Respondent marital status
Married 66.3
Never married 16.3
Divorced 10.4
Separated 3.0
Widowed 1.9
Age of patient at enrollment,
age range: o1–84 years
35.7 (22.5)
Diagnostic category
Cancer 27.8
Cardiovascular disorder 6.7
Neurodevelopmental disorder 27.4
Congenital malformations 7.0
Retina 9.3
Other (eg., mitochondrial disorder) 21.9
Prior genetic testing (N=251) 71.7
Illness Uncertainty Scale (mean),
score range: 1.17–4.26
2.73 (0.72)
Subjective social status (N=260), score range: 1–10 5.86 (1.88)
Number of kinds of information hoped for (sum),
score range: 0–5
3.87 (1.02)
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Family implications
As participants’ illness uncertainty increased, their odds of mainly
hoping to learn about disease risk in family members decreased by
over one-half (OR= 0.44; 95% CI= 0.24, 0.81; P= 0.008). There were
no significant differences in the odds of mentioning family implica-
tions as a main hope across status categories (Ps40.100).
DISCUSSION
Patients and parents of pediatric patients in the current study were
hoping to learn multiple kinds of information from WES results. In
line with the psychosocial and practical challenges of living with an
unexplained or undiagnosed condition, participants’ descriptions of
their main hopes were largely aimed at receiving an explanation for
the illness, information about treating it, a diagnosis (ie, a name or
label for the condition), and information about disease risk in family
members. These findings are similar to those found for oncology
patients5 and parents of pediatric patients with rare conditions6 but
are unlike findings for adults at risk for coronary artery disease whose
hopes to help others or advance medical science figured more
prominently.4 Such similarities and differences from prior research
suggest that how people prioritize hopes for genomic sequencing may
vary by health context. In line with the goal-directed theory of hope,8,9
participants’ uncertainty about their (or their child’s) illness and, to a
lesser extent, their subjective social status appeared to influence how
much and what kinds of information they hoped to learn from WES.
Patients and parents who felt uncertain about the cause, nature,
and/or future implications of their (or their child’s) illness hoped for
more kinds of information than those who felt less uncertain. Thus,
illness uncertainty may be a key motivator to have diagnostic
sequencing by shaping how patients view the range of benefits from
sequencing information. Findings also suggested that illness uncer-
tainty influences what kinds of information patients hope to learn.
Table 2 The number of kinds of information hoped for from WES and attendant genetic counseling as a function of illness uncertainty and
subjective social status
Predictora β t B (SE) B 95% CI P
Respondent role 0.19 2.74 0.43 (0.16) 0.12, 0.74 0.007
Prior genetic testing −0.16 −2.29 −0.38 (0.17) −0.71, −0.05 0.023
Respondent race/ethnicity 0.06 0.95 0.17 (0.17) −0.18, 0.51 0.345
Patient functional statusb 0.14 2.04 0.15 (0.07) 0.005, 0.29 0.042
Household income 0.02 0.25 0.007 (0.03) −0.05, 0.06 0.801
Educational attainment −0.07 −0.96 −0.16 (0.17) −0.48, 0.17 0.168
Illness uncertainty 0.29 3.76 0.44 (0.12) 0.21, 0.67 o0.001
Subjective social status 0.14 1.78 0.08 (0.05) −0.01, 0.17 0.077
aRespondent role, prior genetic testing experience, respondent race/ethnicity, and patient functional status were entered in the first block of hierarchical regression analyses (Adj. R2=0.06; F
change P=0.002); household income and highest educational attainment were entered in the second block (Adj. R2=0.05; F change P=0.627); and illness uncertainty and subjective social
status were entered in the third block (Adj. R2=0.12; F change Po0.001).
bVariable created by combining standardized functional status scores for adults and pediatric patients; higher scores correspond with poorer physical functioning and greater disability.
Table 3 Codes for participant open-ended responses for the main thing they hope to get out of WES and attendant genetic counseling and
percentages of participants (N=269)
Code Definition/behavior Example Participants
Cause (self/
child)
Explanation for condition; why; cause; to find out if condition is genetic I would like to find out if it is a genetic problem the
reason he has epilepsy
119 (44.2%)
Treatment
(self/child)
What can I do to manage condition and improve health Maybe a vitamin supplement to decrease difficulty 98 (36.4%)
Diagnosis
(self/child)
Diagnosis; what is this condition; what is wrong with me/my child To get to the bottom of what I have, and see at one point what
this may be
72 (26.8%)
Family
implications
Present and future risk for biological relatives Information that would help my children and grandchildren lead
healthier and longer lives
62 (23.0%)
Future implica-
tions (self/
child)
What’s going to happen in the future?; what to expect for the future;
actions to take in future
To see if there will be any other kind of cancer or any other kind of
cancer or severe health problems I might get
32 (11.9%)
Help others
(non-family)
Help others with similar condition I hope that my sequencing can be a help to someone else 31 (11.5%)
Advance
science
Advance medical research, understanding of condition I hope it gives more information for research and diagnosis in
general
16 (5.9%)
Miscellaneous Could not be classified If there is something to know, so that we can move on 14 (5.2%)
Knowledge To know more; just to know; to learn; curiosity; to have information.
Code only used when no specific reason was given for wanting knowledge
To have more information to be more knowledgeable 12 (4.5%)
Prevention
(self/child)
Keeping condition from getting worse; preventing future conditions Anything I am predisposed to so that I can prevent it 8 (3.0%)
Family
planning
Deciding to have children; future pregnancies To maybe gather information so that my wife and I can decide for
family planning whether it is a good idea to have children
5 (1.9%)
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When patients are unsure of the identity of their illness or are unsure
of how to treat it, they may focus their hopes for WES on themselves.
By contrast, when patients have a better understanding of their illness,
they may hope to learn if their family members are at risk to help their
family members prepare for the possibility of future illness.
Subjective social status was marginally linked to the amount of
information patients and parents hoped to learn from WES; however,
findings revealed differences in the kinds of information that they were
mainly hoping to learn. Participants from all subjective social status
groups hoped to learn the cause of their illness, but the breadth of
additional hopes mentioned varied across status groups. Low-status
participants were overwhelmingly hoping to learn the cause of their
illness, whereas the hopes of moderate-status participants appeared
more varied. The hopes of high-status participants more narrowly
focused on hoping to learn the cause of their illness and information
about disease risk in family members. Thus patients’ perceptions of
their social and economic resources may shape their priorities for
information from sequencing results.
Findings also raise the question of how to encourage realistic hopes
and downplay unrealistic hopes for genomic sequencing. Some
patients and families may hope for more information than genomic
sequencing can feasibly provide at this time. Unrealistic hopes may
needlessly predispose patients and families to greater distress when
hopes for sequencing results are inevitably unmet. Poor health literacy
and numeracy,22 unfamiliarity with genetics terminology and patterns
of inheritance,23 and inevitable shifts in interpretation and return of
results with advances in genomic medicine24,25 complicate the
communication of strengths and limitations of genomic sequencing.
Taking into account patients’ level of illness uncertainty and perceived
resources could inform the development of guidelines for provider
communication by helping providers ascertain patients’ frame of
reference for their hopes. It could also inform the development of
educational resources that help patients clarify their priorities and
make informed decisions.
Limitations and future directions
The current study extends prior research on people’s hopes for
genomic sequencing4–6 by investigating predictors of hope in adult
patients and parents of pediatric patients in a real-world, clinical
setting. The hopes of patients and parents reflected personally relevant
information that could potentially influence their psychological well-
being, beliefs about the condition, and subsequent health decisions.
Nonetheless, study limitations remain that could serve as future
research directions.
One limitation is that patients’ and parents’ hopes were based on
one time point. Whereas some have suggested that being hopeful is a
relatively stable individual difference,8,9 others have suggested that
patients’ hopes can change as a function of adaptation to an illness.2
Although patients’ and parents’ hopes for information from WES and
genetic counseling were assessed through close-ended and open-ended
questions, our methods for measuring and coding hope may not have
fully captured the entire scope of the emotional26 and cognitive9
aspects of hope. Findings from the exploratory content analysis of
the dual hopes for cause and diagnosis should be interpreted for the
purpose of hypothesis generation in future research. It is also unclear
whether patients and parents distinguished their hopes for WES from
genetic counseling. For instance, participants may have hoped that
WES results could elucidate a cause, but they may have hoped that
genetic counseling would provide reassurance. Finally, participants’
hopes for WES may be driven by other forms of motivation or
perceived means. For example, participants could also be motivated by
personal beliefs about their illness or family history. Participants’
perceptions of their means to use information fromWES could also be
influenced by access to health-care providers or insurance coverage.
For patients grappling with an unexplained or difficult-to-diagnose
condition, hope is an important resource for psychological well-being
and resilience. The growth of clinical sequencing will necessitate
finding ways to foster patients’ hope while also educating them about
the limitations of diagnostic sequencing. Understanding why patients
hope for certain information could help providers tailor their
communication and inform the development of educational resources
that enable informed decisions surrounding genomic sequencing and
its applications to health care.
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